These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18338222)

  • 41. Pyrazole CCK(1) receptor antagonists. Part 1: Solution-phase library synthesis and determination of Free-Wilson additivity.
    McClure K; Hack M; Huang L; Sehon C; Morton M; Li L; Barrett TD; Shankley N; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Jan; 16(1):72-6. PubMed ID: 16236513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global Assessment of Substituents on the Basis of Analogue Series.
    Takeuchi K; Kunimoto R; Bajorath J
    J Med Chem; 2020 Dec; 63(23):15013-15020. PubMed ID: 33253557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors.
    Chen XM; Lu T; Lu S; Li HF; Yuan HL; Ran T; Liu HC; Chen YD
    J Mol Model; 2010 Jul; 16(7):1195-204. PubMed ID: 20020310
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MEPHAS: an interactive graphical user interface for medical and pharmaceutical statistical analysis with R and Shiny.
    Zhou Y; Leung SW; Mizutani S; Takagi T; Tian YS
    BMC Bioinformatics; 2020 May; 21(1):183. PubMed ID: 32393166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrazole CCK(1) receptor antagonists. Part 2: SAR studies by solid-phase library synthesis and determination of Free-Wilson additivity.
    Sehon C; McClure K; Hack M; Morton M; Gomez L; Li L; Barrett TD; Shankley N; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Jan; 16(1):77-80. PubMed ID: 16236506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics.
    Steinbeck C; Hoppe C; Kuhn S; Floris M; Guha R; Willighagen EL
    Curr Pharm Des; 2006; 12(17):2111-20. PubMed ID: 16796559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MB-Isoster: A software for bioisosterism simulation.
    Elias TC; de Oliveira HCB; da Silveira NJF
    J Comput Chem; 2018 Nov; 39(29):2481-2487. PubMed ID: 30318630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Revisiting the Structure and Chemistry of 3(5)-Substituted Pyrazoles.
    Secrieru A; O'Neill PM; Cristiano MLS
    Molecules; 2019 Dec; 25(1):. PubMed ID: 31877672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From magic bullets to designed multiple ligands.
    Morphy R; Kay C; Rankovic Z
    Drug Discov Today; 2004 Aug; 9(15):641-51. PubMed ID: 15279847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving the utility of molecular scaffolds for medicinal and computational chemistry.
    Bajorath J
    Future Med Chem; 2018 Jul; 10(14):1645-1648. PubMed ID: 29957045
    [No Abstract]   [Full Text] [Related]  

  • 55. Diversity in medicinal chemistry space.
    Gorse AD
    Curr Top Med Chem; 2006; 6(1):3-18. PubMed ID: 16454754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME.
    Glem RC; Bender A; Arnby CH; Carlsson L; Boyer S; Smith J
    IDrugs; 2006 Mar; 9(3):199-204. PubMed ID: 16523386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
    Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
    Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. InfVis--platform-independent visual data mining of multidimensional chemical data sets.
    Oellien F; Ihlenfeldt WD; Gasteiger J
    J Chem Inf Model; 2005; 45(5):1456-67. PubMed ID: 16180923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synchronized 2D/3D optical mapping for interactive exploration and real-time visualization of multi-function neurological images.
    Zhang Q; Alexander M; Ryner L
    Comput Med Imaging Graph; 2013; 37(7-8):552-67. PubMed ID: 23968722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Target family-directed exploration of scaffolds with different SAR profiles.
    Hu Y; Bajorath J
    J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.